Cargando…
A Monovalent Mt10-CVB3 Vaccine Prevents CVB4-Accelerated Type 1 Diabetes in NOD Mice
Enteroviruses, which include Coxsackieviruses, are a common cause of virus infections in humans, and multiple serotypes of the group B Coxsackievirus (CVB) can induce similar diseases. No vaccines are currently available to prevent CVB infections because developing serotype-specific vaccines is not...
Autores principales: | Rasquinha, Mahima T., Lasrado, Ninaad, Sur, Meghna, Mone, Kiruthiga, Qiu, Haowen, Riethoven, Jean-Jack, Sobel, Raymond A., Reddy, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864234/ https://www.ncbi.nlm.nih.gov/pubmed/36679922 http://dx.doi.org/10.3390/vaccines11010076 |
Ejemplares similares
-
Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses
por: Lasrado, Ninaad, et al.
Publicado: (2021) -
Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis
por: Lasrado, Ninaad, et al.
Publicado: (2021) -
Vaccines against Group B Coxsackieviruses and Their Importance
por: Mone, Kiruthiga, et al.
Publicado: (2023) -
Transgenic Mice Expressing Functional TCRs Specific to Cardiac Myhc-α 334–352 on Both CD4 and CD8 T Cells Are Resistant to the Development of Myocarditis on C57BL/6 Genetic Background
por: Sur, Meghna, et al.
Publicado: (2023) -
The Bioactive Phenolic Agents Diaryl Ether CVB2-61 and Diarylheptanoid CVB4-57 as Connexin Hemichannel Blockers
por: Dierks, Anne, et al.
Publicado: (2022)